BiomX – A Unique Microbiome Company with Substantial Market Potential

BiomX is a microbiome company that develops customized phage therapies aimed to treat chronical diseases, including inflammatory bowel disease (IBD) and colorectal-cancer (CRC), as well as acne that affects the skin appearance, which present significant market potentials.

Download Report

2019-11-12T13:38:49+08:00 November 12th, 2019|BlomX|